Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lesko

Showing results (661-670 of 1,126) with videos related to

Pageof 113
Sort By:
Biomedicines|March 25, 2022
The Interplay of Cx26, Cx32, Cx37, Cx40, Cx43, Cx45, and Panx1 in Inner-Ear Development of Yotari (dab1-/-) Mice and HumansJosip Lesko, Pejana Rastović, Josip Mišković, et al.
Journal of Surgical Oncology|November 1, 1996
Pharmacokinetics of dacarbazine in the regional perfusion of extremities with melanomaM S Didolkar, A J Jackson, L J Lesko, et al.
Journal of Pharmacokinetics and Pharmacodynamics|April 27, 2020
A clinical population pharmacokinetic/pharmacodynamic model for BIIB059, a monoclonal antibody for the treatment of systemic and cutaneous lupus erythematosusSonja Hartmann, Konstantinos Biliouris, Himanshu Naik, et al.
Frontiers in Neurology|April 12, 2021
Case Report: A Novel Mutation in the Mitochondrial <i>MT-ND5</i> Gene Is Associated With Leber Hereditary Optic Neuropathy (LHON)Martin Engvall, Aki Kawasaki, Valerio Carelli, et al.
Journal of Clinical Pharmacology|April 29, 1998
Defining the maximum tolerated dose: investigator, academic, industry and regulatory perspectivesN R Cutler, J J Sramek, D J Greenblatt, et al.
Pediatrics|March 4, 2003
Sleep position of low birth weight infantsLouis Vernacchio, Michael J Corwin, Samuel M Lesko, et al.
Clinical Pharmacology and Therapeutics|October 3, 2000
In vivo drug-drug interaction studies--a survey of all new molecular entities approved from 1987 to 1997P J Marroum, R S Uppoor, T Parmelee, et al.
Psychosomatics|January 1, 1992
Fellowship training objectives and readings in consultation-liaison transplantation psychiatryA M Riether, B J Lewison, S A Cohen-Cole, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 1, 2018
A pre-clinical quantitative model predicts the pharmacokinetics/pharmacodynamics of an anti-BDCA2 monoclonal antibody in humansKonstantinos Biliouris, Ivan Nestorov, Himanshu Naik, et al.
The Journal of Allergy and Clinical Immunology|April 1, 1997
Production of IL-5 and granulocyte-macrophage colony-stimulating factor by naive human mast cells activated by high-affinity IgE receptor ligationR B Bressler, J Lesko, M L Jones, et al.
Pageof 113

Showing results (661-670 of 1,126) with videos related to

Sort By:
Pageof 113
Biomedicines|March 25, 2022
The Interplay of Cx26, Cx32, Cx37, Cx40, Cx43, Cx45, and Panx1 in Inner-Ear Development of Yotari (dab1-/-) Mice and HumansJosip Lesko, Pejana Rastović, Josip Mišković, et al.
Journal of Surgical Oncology|November 1, 1996
Pharmacokinetics of dacarbazine in the regional perfusion of extremities with melanomaM S Didolkar, A J Jackson, L J Lesko, et al.
Journal of Pharmacokinetics and Pharmacodynamics|April 27, 2020
A clinical population pharmacokinetic/pharmacodynamic model for BIIB059, a monoclonal antibody for the treatment of systemic and cutaneous lupus erythematosusSonja Hartmann, Konstantinos Biliouris, Himanshu Naik, et al.
Frontiers in Neurology|April 12, 2021
Case Report: A Novel Mutation in the Mitochondrial <i>MT-ND5</i> Gene Is Associated With Leber Hereditary Optic Neuropathy (LHON)Martin Engvall, Aki Kawasaki, Valerio Carelli, et al.
Journal of Clinical Pharmacology|April 29, 1998
Defining the maximum tolerated dose: investigator, academic, industry and regulatory perspectivesN R Cutler, J J Sramek, D J Greenblatt, et al.
Pediatrics|March 4, 2003
Sleep position of low birth weight infantsLouis Vernacchio, Michael J Corwin, Samuel M Lesko, et al.
Clinical Pharmacology and Therapeutics|October 3, 2000
In vivo drug-drug interaction studies--a survey of all new molecular entities approved from 1987 to 1997P J Marroum, R S Uppoor, T Parmelee, et al.
Psychosomatics|January 1, 1992
Fellowship training objectives and readings in consultation-liaison transplantation psychiatryA M Riether, B J Lewison, S A Cohen-Cole, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 1, 2018
A pre-clinical quantitative model predicts the pharmacokinetics/pharmacodynamics of an anti-BDCA2 monoclonal antibody in humansKonstantinos Biliouris, Ivan Nestorov, Himanshu Naik, et al.
The Journal of Allergy and Clinical Immunology|April 1, 1997
Production of IL-5 and granulocyte-macrophage colony-stimulating factor by naive human mast cells activated by high-affinity IgE receptor ligationR B Bressler, J Lesko, M L Jones, et al.
Pageof 113